Search Results for: fda

Call to patients: let’s advocate together for stem cell clinic publishing

In this post I propose that researchers and patients advocate together to pressure the stem cell clinic industry to collect and publish such data. Why do I make such a proposal? Many thousands of patients have bought stem cell interventions from non-compliant stem cell clinics. Thousands of others are considering doing so. You can see

Call to patients: let’s advocate together for stem cell clinic publishing Read More »

Kathy Ireland Stemáge Stem Cell Product: Part 1, is it a drug?

Kathy-Ireland-300x2191

I was alerted by a friend to the fact that there are now YouTube ads for stem cell products popping up, and one such ad features supermodel Kathy Ireland pitching for something called Stemáge Skin Care. Updated (May 23): note that preliminary word from Sanford-Burnham is that they are not collaborating on Stemáge. Today’s post is

Kathy Ireland Stemáge Stem Cell Product: Part 1, is it a drug? Read More »

Stem cell company Intellicell facing new financial wrinkles

Intellicell

It’s difficult to make it as a biotech company, I would say stem cell biotechs in general may have an even rougher time, and one such company,  Intellicell (Intellicell Biosciences, Inc), is showing a number of signs of distress in my opinion. An online financial tool predicts the probability of companies going bankrupt within the next

Stem cell company Intellicell facing new financial wrinkles Read More »

Jeanne Loring interview: optimism on clinical translation of IPS cells

Loring-in-lab-1

One of my favorite stem cell scientists is Jeanne Loring of Scripps. She does great science and when you ask her questions, she frankly states her opinions and is clearly a gifted educator at heart too. Below is a Q&A interview I did with Jeanne on key issues of clinical translation of iPS cells. You

Jeanne Loring interview: optimism on clinical translation of IPS cells Read More »